Canadian Implantable Defibrillator Study (CIDS): Study design and organization
References (15)
- et al.
Long-term outcome with the automatic implantable cardioverter defibrillator
J Am Coll Cardiol
(1989) - et al.
Time to first shock and clinical outcome of patients receiving an automatic implantable cardioverter defibrillator
J Am Coll Cardiol
(1989) - et al.
Survival in patients declining implantable cardioverter defibrillators
Am J Cardiol
(1991) - et al.
Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS)
J Am Coll Cardiol
(1990) - et al.
Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study
J Am Coll Cardiol
(1992) - et al.
Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation
J Am Coll Cardiol
(1989) - et al.
Five year follow-up of 589 patients treated with amiodarone
Am Heart J
(1993)
There are more references available in the full text version of this article.
Cited by (138)
Non-invasive programmed stimulation vs. electrophysiological study in patients with pacemaker
2016, IJC Metabolic and EndocrineEffect of early changes in functional geometry of left ventricular contraction on the development of ventricular fibrillation during acute myocardial ischaemia. An experimental study
2011, ResuscitationCitation Excerpt :Early ventricular arrhythmias during the first 30 min of myocardial ischaemia occur in a biphasic temporal distribution – that is, phase 1a (“immediate”) and phase 1b (“delayed”). The early (during the first 30 min after acute coronary occlusion) incidence of primary VF complicating acute MI has been extensively documented in previous studies.1–9 These studies consistently showed a causal association between VF and the post-infarction LV cavity dilatation, cell-to-cell interaction,6 and elevation of plasma levels of adrenergic neurohormones.8
Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator
2002, American Heart JournalPatients with sudden cardiac death receiving an implantable cardiac device: Survival at 30 days and one year
2020, Revista Medica de ChileArrhythmia
2014, The Cardiology Intensive Board Review: Third Edition
Copyright © 1993 Published by Elsevier Inc.